These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone. Vieta E, Nieto E, Autet A, Rosa AR, Goikolea JM, Cruz N, Bonet P. World J Biol Psychiatry; 2008 Nov; 9(3):219-24. PubMed ID: 18609430 [Abstract] [Full Text] [Related]
8. Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder. Fagiolini A, Casamassima F, Mostacciuolo W, Forgione R, Goracci A, Goldstein BI. Expert Opin Pharmacother; 2010 Jul; 11(10):1727-40. PubMed ID: 20486830 [Abstract] [Full Text] [Related]
9. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium. Yoshimura R, Ueda N, Shinkai K, Nakamura J. Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648 [Abstract] [Full Text] [Related]
12. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder. Gianfrancesco FD, Sajatovic M, Tafesse E, Wang RH. Ann Clin Psychiatry; 2009 Apr; 21(1):3-16. PubMed ID: 19239828 [Abstract] [Full Text] [Related]
13. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Yoshimura R, Nakano Y, Hori H, Ikenouchi A, Ueda N, Nakamura J. Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305 [Abstract] [Full Text] [Related]
14. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
15. Medication adherence and the use of long-acting antipsychotics in bipolar disorder. El-Mallakh RS. J Psychiatr Pract; 2007 Mar; 13(2):79-85. PubMed ID: 17414683 [Abstract] [Full Text] [Related]
16. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series. Saxena K, Chang K, Steiner H. Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141 [Abstract] [Full Text] [Related]
18. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder. MacMillan CM, Withney JE, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez-Heydrich JM. J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785 [Abstract] [Full Text] [Related]
19. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V. Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994 [Abstract] [Full Text] [Related]
20. Therapeutic drug monitoring of patients on risperidone depot. Nesvåg R, Tanum L. Nord J Psychiatry; 2005 Nov; 59(1):51-5. PubMed ID: 16195099 [Abstract] [Full Text] [Related] Page: [Next] [New Search]